Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
12/2010
12/14/2010US7850990 Compositions for delivery of drug combinations
12/14/2010US7850959 Methods and compositions for treating conditions involving abnormal angiogenesis
12/14/2010US7850946 intramolecular linked drug/biological conjugates, that absorb and emit light in the near infrared region of electromagnetic spectrum, having improved stability, high receptor binding affinity and pharmacokinetics, useful as imaging or contrast agents
12/14/2010CA2420292C Contraception process and administration form for the same
12/09/2010US20100311762 Reduction of toxicity of multi-targeting antifolates
12/09/2010US20100311189 Novel Receptor Nucleic Acids and Polypeptides
12/08/2010EP2258869A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258868A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258867A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258848A1 Il-17 homologous polypeptide and therapeutic uses thereof
12/08/2010EP2258841A1 Methods for treating pain
12/08/2010EP2258711A2 New forms of 5-azacytidine
12/08/2010EP2258710A1 New polymorphic form of 5-azacytidine
12/08/2010EP2258699A1 Polymorphs of a pyrrole-substituted 2-Indolinone protein kinase inhibitor
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258677A2 Histone deacetylase inhibitors and methods of use thereof
12/08/2010EP2258347A2 Tamper-resistant products for opioid delivery
12/08/2010EP2258342A2 Improvements in and relating to carrier particles for use in dry powder inhalers
12/08/2010EP1007017B2 Budesonide / formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof
12/08/2010CN1794963B Hemorrhoid treatment device
12/08/2010CN101904812A Compositions and methods for transdermal oxybutynin therapy
12/07/2010US7848888 Method for identification of biologically active agents
12/07/2010US7847146 Model for neurodegenerative disorders
12/07/2010US7846904 Compositions and methods for increasing telomerase activity
12/07/2010CA2381802C Synergistic combination of roflumilast and salmeterol
12/07/2010CA2354763C Method for forming striped dentifrice upon extrusion from partially transparent container
12/02/2010US20100305199 Therapeutic regimen for treating cancer
12/02/2010US20100305141 Tetrahydroindolone derivatives for treatment of neurological conditions
12/02/2010US20100305107 Quinoline derivatives and their use as 5-ht6 ligands
12/02/2010US20100305048 Novel use of cytokine inhibitors
12/02/2010US20100303929 Compounds and methods for treating cancer
12/02/2010US20100303810 Method for treating lupus
12/01/2010EP2255798A2 Sphingosine-1-phosphate receptor agonists for use in the treatment of optic neuritis
12/01/2010EP1590336B1 Substituted pyrazoles, compositions containing such compounds and methods of use
12/01/2010CN1913896B Methods and compositions for the treatment and management of hemoglobinopathy and anemia
12/01/2010CN1809584B Compositions comprising cationic microparticles and HCV E1E2 DNA and methods of use thereof
12/01/2010CN1763181B Vaccine against mumps containing a JERYL-LYNN virus strain
12/01/2010CN1723042B Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
12/01/2010CN1703205B Extended, controlled-release pharmaceutical compositions using charged polymers
12/01/2010CN101898982A Npy y5 antagonists
12/01/2010CN101002758B Use of composition for treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
11/2010
11/30/2010US7842835 Increasing sensitivity of cancer cells to radiotherapy cytotoxic effects; neurological diseases; such as n-hydroxy-4-[3-(2-hydroxy-2-phenyl-ethyl)-ureido]-butyramide
11/30/2010US7842802 Vinorelbine derivatives
11/30/2010US7842691 Method for the treatment of myelodysplastic syndromes using cyclopropanecarboxylic acid {2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-OXO-2,3-dihydro-1 H-isoindol-4-yl}-amide
11/30/2010US7842680 Diene and triene compounds and formulations
11/30/2010CA2513440C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
11/30/2010CA2430772C Humanized antibodies that recognize beta amyloid peptide
11/25/2010US20100298276 Thyroid receptor ligands
11/25/2010US20100298253 Pharmaceutical Compositions Comprising Forms of 5-Azacytidine
11/25/2010US20100297267 Compositions for diabetes treatment and prophylaxis
11/25/2010US20100297220 Pharmaceutical Formulation And Method For Treating Acid-Caused Gastrointestinal Disorders
11/25/2010US20100297150 Disease treatment via antimicrobial peptide inhibitors
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/24/2010EP1438418B1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
11/24/2010CN1897937B 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
11/23/2010US7838548 antagonists; oligopeptide of N-(3-indolylacetyl)-L-isoleucine and glycine; IBD, sepsis, periodontal disease, mucositis, acne, cardiovascular disease, COPD, arthritis, cystic fibrosis, infections, ischemia/reperfusion, asthma, stroke, brain injuries, enterocolitis, bed sores, leprosy, atopic dermatitis
11/23/2010US7838220 T cell regulatory genes associated with immune disease
11/23/2010US7838217 detecting a predisposition to noncryptogenic hepatobiliary disease; viral hepatitis, biliary atresia, alcoholic cirrhosis
11/23/2010US7838024 Multicompartment drug delivery system for use in treatment of menopausal symptoms and benign ovarian secretory disorder; contraceptive
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292162 Socs-3 promoter methylation in cancer
11/18/2010US20100291138 Vaccine
11/18/2010US20100291001 Metalloproteinase-binding proteins
11/17/2010EP2251327A2 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2010EP2251007A2 Sphingosine-1-phosphate (S1P) receptor agonists for use in the treatment of demyelinating diseases
11/17/2010EP1624899B1 INCREASED TRANSDUCTION USING ABC TRANSPORTER SUBSTRATES that are INHIBITORS
11/17/2010EP1545597B1 Immunostimulatory compositions and methods of stimulating an immune response
11/16/2010US7834147 Saposin C-DOPS: a novel anti-tumor agent
11/16/2010US7833998 cephalosporin sulfoxides or sulfones; carboxypeptidase E inhibitors; neurological disease, a behavioral disorder, or a cognitive disorder;
11/16/2010US7833545 Methods and devices for the sustained release of multiple drugs
11/16/2010US7833237 Instrument for assisting in the remote placement of tied surgical knots and trimming of suture away from the knot and method of use
11/16/2010CA2429205C Dermatological formulations
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/16/2010CA2330659C Using ngali nut oil to treat/relieve manifestations of arthritis and other similar conditions
11/16/2010CA2261334C Bovine polynucleotide vaccine for the intradermal route
11/10/2010EP1633340B1 Compounds for the treatment of metabolic disorders
11/10/2010EP1556081B1 Recombinant intracellular pathogen immunogenic compositions and methods for use
11/10/2010EP1487483B1 Chimeric infectious dna clones of porcine circovirus and uses thereof
11/10/2010EP1039882B1 Therapeutic formulation for administering tolterodine with controlled release
11/10/2010CN1874781B Compositions of botanical extracts for cancer therapy
11/10/2010CN1561208B Methods to mobilize progenitor/stem cells
11/10/2010CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases
11/09/2010US7829682 human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP; for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP
11/09/2010US7829616 anhydrous; polyethylene glycol; ethylene oxide-propylene oxide copolymer; biocompatible; handling characteristics (hardness, ductility, malleability) that range from a grease to a wax for medical and surgical applications; bone hemostat; implant; adhesive; thermoreversible hydrogel drug delivery
11/09/2010US7829597 preventing the formation of insoluble A beta and arresting the production of A beta; beta-site amyloid precursor protein-cleaving enzyme; 3-[(2-amino-2-methyl-3-phenylpropoxy)methyl]-N-[(1R)-1-(4-fluorophenyl)ethyl]-[methyl(methylsulfonyl)amino]benzamide
11/09/2010US7829552 Phosphorus-containing thyromimetics
11/09/2010US7829529 Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
11/09/2010US7829503 Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-fungal agents
11/09/2010US7829297 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor
11/09/2010US7829290 Method and device for protein delivery into cells
11/09/2010US7829112 Forming two drug permeable polymeric segments, exposing to preferential drug, connecting segments, delivering drug treatment; for use in treatment of menopausal symptoms and benign ovarian secretory disorder; contraceptive
11/09/2010US7829082 Catheter composition and uses thereof
11/09/2010US7829064 antigen binding molecules conjugated to lipids, polymer carriers, micelles, nanoparticles or mixtures and effectors, used for therapy of diagnosis
11/09/2010CA2438544C Aerosol compositions containing formoterol for delivery to the lungs via nebulization
11/09/2010CA2397583C New aminopropylphosphinic acids
11/09/2010CA2161684C Bioactive and/or targeted dendrimer conjugates
11/09/2010CA2137815C Dna sequences used in the production of recombinant human bssl/cel in transgenic non-human mammals, and the produced bssl/cel used in infant formulas
11/04/2010US20100280075 Paclitaxel enhancer compounds
11/04/2010US20100280066 Acylated amino acid amidyl pyrazoles and related compounds
11/04/2010US20100280042 Quinazoline derivatives for the treatment of tumours
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 295